LLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?

The breakthrough in weight-loss medication has shaken the healthcare trade. Goldman Sachs Analysis expects weight-loss medication to spice up U.S. gross home product (GDP) by 0.4% in a baseline situation with 30 million customers and drive a 1% rise when customers attain 60 million. Additional, Goldman Sachs expects the weight-loss medication market to succeed in…